Skip to main content
. 2022 Jan 20;14(3):511. doi: 10.3390/cancers14030511
CCR8 CC chemokine receptor 8
CTLA-4 cytotoxic T lymphocyte associated protein-4
PD-1/PD-L1 program death receptor-1/ program death receptor-1 ligand-1
irAEs immune-related adverse events
CBIs checkpoint blockade inhibitors
Treg/aTreg regulatory T cells/activated regulatory T cells
Tconv conventional T cell
Teff effector T cell
NK natural killer cell
DC/iDC dendritic cell/inhibitory dendritic cell
MDSC myeloid derived suppressor cell
Mf macrophage
CAF cancer associated fibroblast
TAM tumor associated macrophage
IFN-g interferon gamma
TNF-a tumor necrosis factor alpha
TGF-b transforming growth factor beta
TRP tryptophane
KYN N-formyl-kynurenine
IDO indoleamine 2,3-dioxygenase
EMT epithelial mesenchymal transition
CSC cancer stem cell